Ganga Pharmaceuticals Ltd

BSE: 539680
Ganga Pharmaceuticals Ltd - healthcare in Palghar, Maharashtra, India. FY 2026 financials and compliance.
CIN L99999MH1989PLC053392 Incorporated 11 September 1989 ROC Mumbai HQ Palghar, Maharashtra, India
Active Listed - BSE: 539680 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹2.83 Cr
▲ 7.22% YoY
EBITDA · FY 2026
Locked
In full report
Net profit · FY 2026
₹10.15 Lakh
▲ 28.48% YoY
Authorised capital
₹7.5 Cr
Registered with MCA
Paid-up capital
₹5.91 Cr
Issued & subscribed
Open charges
₹2.18 Cr
Satisfied ₹12.26 Cr
Company age
37 yrs
Est. 1989
Last financials
Mar 2025
Balance sheet date

About Ganga Pharmaceuticals Ltd

Data last updated: 14 July 2026

Ganga Pharmaceuticals Ltd is a public limited company based in Palghar, Maharashtra, India. It specialises in ayurvedic products and services, a part of the broader healthcare sector. Incorporated on 11 September 1989, the company has been in operation for over 37 years.

Registered with ROC Mumbai under CIN L99999MH1989PLC053392. Listed on BSE: 539680.

Capital: an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.91 Cr. It is led by directors including Bharat Brijmohan Sharma and Sanjay Vyankatesh Kulkarni.

Last AGM: 20 September 2025. Financial statements filed for year ended 31 March 2025. Office: Gangatat Dhanvantri Marg Gopcharpada Virar (E) Palghar – 401305, Maharashtra, India – 401305.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹2.83 Cr, a growth of 7.22% compared to the previous year. The net worth stands at ₹5.91 Cr (up 22.23% YoY). Total assets are valued at ₹9.65 Cr (up 7.55% YoY).

The company is associated with 1 brand - Ganga Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.18 Cr and satisfied charges of ₹12.26 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ayurvedganga.com.

Company Details of Ganga Pharmaceuticals Ltd
CIN L99999MH1989PLC053392
Registration Number 053392
Incorporation Date 11 September 1989
ROC Mumbai
Listing Status Listed (BSE: 539680)
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Bharat Brijmohan Sharma Managing Director Srijna Sharma Whole-Time Director Sanjay Vyankatesh Kulkarni Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    ayurvedganga.com
  • Social Media
    Locked
  • Registered Address
    Gangatat Dhanvantri Marg Gopcharpada Virar (E) Palghar – 401305, Maharashtra, India – 401305
  • Industry
    Healthcare, Ayurvedic Products & Services
Company report
Ganga Pharmaceuticals Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ganga Pharmaceuticals Ltd report

Financials, compliance, directors, charges, ownership and filings for Ganga Pharmaceuticals Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd operates one associated brand: Ganga Pharmaceuticals. These brands represent Ganga Pharmaceuticals Ltd's diversified market presence and brand portfolio.

Brand Description Website
Ganga Pharmaceuticals
Provider of local news and information ayurvedganga.com

Business Activity of Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Ganga Pharmaceuticals Ltd

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd is audited by Banka and Banka (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Banka and Banka (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd is currently managed by 5 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bharat Brijmohan Sharma Managing Director 11 Sep 1989 36 Years 10 Months Current
Sanjay Vyankatesh Kulkarni Director 01 Apr 2012 14 Years 3 Months Current
Srijna Sharma Whole-Time Director 01 Apr 2012 14 Years 3 Months Current
Munna Baijnath Chaurasia Director 27 Mar 2025 1 Years 3 Months Current
Aman Mukesh Chaudhari
Also directs: Riveroak Solutions Private Limited
Director 27 Mar 2025 1 Years 3 Months Current
View all directors

Financials of Ganga Pharmaceuticals Ltd FY 2026 filings available

Ganga Pharmaceuticals Ltd reported revenue of ₹2.83 Cr (up 7.22% YoY) for FY 2026.

Revenue · FY 2026
₹2.83 Cr ▲ 7.22%
Profit · FY 2026
₹10.15 Lakh ▲ 28.48%
Revenue₹ Cr · Standalone024FY 2019: ₹3 Cr3.4FY 2019FY 2020: ₹3 Cr · -8.4% YoY3.1-8.4%FY 2020FY 2021: ₹2 Cr · -22.9% YoY2.4-22.9%FY 2021FY 2022: ₹2 Cr · +4.8% YoY2.5+4.8%FY 2022FY 2023: ₹3 Cr · +3.9% YoY2.6+3.9%FY 2023FY 2024: ₹3 Cr · +5.8% YoY2.7+5.8%FY 2024FY 2025: ₹3 Cr · -3.6% YoY2.6-3.6%FY 2025FY 2026: ₹3 Cr · +7.2% YoY2.8+7.2%FY 2026
Net Profit₹ Cr · Standalone00.10.2FY 2019: ₹0 Cr0.2FY 2019FY 2020: ₹0 Cr · +1% YoY0.2+1%FY 2020FY 2021: ₹0 Cr · -89.1% YoY0-89.1%FY 2021FY 2022: ₹0 Cr · +84.9% YoY0+84.9%FY 2022FY 2023: ₹0 Cr · +3.6% YoY0+3.6%FY 2023FY 2024: ₹0 Cr · +18.6% YoY0+18.6%FY 2024FY 2025: ₹0 Cr · +69.5% YoY0.1+69.5%FY 2025FY 2026: ₹0 Cr · +28.5% YoY0.1+28.5%FY 2026
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹2.83 Cr ₹2.64 Cr ₹2.74 Cr ₹2.59 Cr ₹2.49 Cr ₹2.37 Cr ₹3.08 Cr ₹3.36 Cr
Other Income ₹27.91 Lakh ₹43.59 Lakh ₹23.95 Lakh ₹29.82 Lakh ₹25.86 Lakh ₹25.43 Lakh ₹16.51 Lakh ₹14.39 Lakh
Total Income ₹3.11 Cr ₹3.07 Cr - - - - - -
Cost of Materials Consumed ₹1.19 Cr ₹1.21 Cr ₹1.32 Cr ₹1.34 Cr ₹1.28 Cr ₹1.42 Cr ₹1.39 Cr ₹1.25 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹11.16 Lakh ₹93,000 -₹7.33 Lakh -₹10.27 Lakh -₹81,000 -₹18.48 Lakh -₹11.42 Lakh -₹1.17 Lakh
Employee Benefit Expense ₹58.83 Lakh ₹57.71 Lakh ₹57.98 Lakh ₹51.1 Lakh ₹43.47 Lakh ₹42.81 Lakh ₹43.63 Lakh ₹44.52 Lakh
Finance Costs ₹13.3 Lakh ₹17.85 Lakh ₹18.46 Lakh ₹19.36 Lakh ₹19.47 Lakh ₹19.42 Lakh ₹24.23 Lakh ₹25.13 Lakh
Other Expenses ₹89.71 Lakh ₹96.17 Lakh ₹85.25 Lakh ₹83.12 Lakh ₹73.6 Lakh ₹67.86 Lakh ₹97.87 Lakh ₹1.26 Cr
Total Expenses ₹2.98 Cr ₹2.98 Cr ₹2.91 Cr ₹2.83 Cr ₹2.7 Cr ₹2.59 Cr ₹2.99 Cr ₹3.25 Cr
Profit Before Tax ₹12.93 Lakh ₹9.47 Lakh ₹6.33 Lakh ₹5.31 Lakh ₹5.12 Lakh ₹3.75 Lakh ₹25.53 Lakh ₹25.84 Lakh
Total Tax Expense ₹2.78 Lakh ₹1.57 Lakh ₹1.67 Lakh ₹1.38 Lakh ₹1.33 Lakh ₹1.7 Lakh ₹6.64 Lakh ₹7.13 Lakh
Net Profit ₹10.15 Lakh ₹7.9 Lakh ₹4.66 Lakh ₹3.93 Lakh ₹3.79 Lakh ₹2.05 Lakh ₹18.89 Lakh ₹18.71 Lakh
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹9.65 Cr ₹8.97 Cr ₹8.65 Cr ₹7.98 Cr ₹8 Cr ₹7.66 Cr ₹7.57 Cr ₹7.76 Cr
Non-current Assets ₹2.08 Cr ₹2.11 Cr ₹2.9 Cr ₹2.84 Cr ₹3.09 Cr ₹3.07 Cr ₹3.15 Cr ₹3.41 Cr
Current Assets ₹7.56 Cr ₹6.87 Cr ₹5.75 Cr ₹5.15 Cr ₹4.91 Cr ₹4.59 Cr ₹4.42 Cr ₹4.35 Cr
Property, Plant & Equipment ₹64.57 Lakh ₹66.46 Lakh - - - - - -
Inventories ₹1.17 Cr ₹1.18 Cr ₹1.24 Cr ₹1.18 Cr ₹1.15 Cr ₹1.13 Cr ₹1.04 Cr ₹1.15 Cr
Cash & Equivalents ₹5.82 Lakh ₹30.24 Lakh ₹2.98 Lakh ₹2.9 Lakh ₹2.04 Lakh ₹1.45 Lakh ₹1.17 Lakh ₹23.65 Lakh
Equity (Net Worth) ₹5.91 Cr ₹4.84 Cr - - - - - -
Current Liabilities ₹1.24 Cr ₹1.6 Cr ₹1.2 Cr ₹1.89 Cr ₹1.69 Cr ₹1.61 Cr ₹1.62 Cr ₹1.94 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹1.31 Cr -₹57.72 Lakh -₹1.26 Cr -₹3.99 Lakh -₹21.07 Lakh
Investing Cash Flow ₹24.37 Lakh ₹1.18 Cr ₹12.96 Lakh ₹49.23 Lakh ₹18.93 Lakh
Financing Cash Flow ₹82.28 Lakh -₹33.15 Lakh ₹1.14 Cr -₹44.39 Lakh ₹2.73 Lakh
Capital Expenditure ₹3.69 Lakh ₹0 - - -
Free Cash Flow (computed) -₹1.35 Cr -₹57.72 Lakh - - -
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹24.42 Lakh ₹27.26 Lakh ₹8,000 ₹85,400 ₹59,300
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Ganga Pharmaceuticals Ltd. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Ganga Pharmaceuticals Ltd

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 50.91%, retail and other public shareholders hold 49.09% of Ganga Pharmaceuticals Ltd. The company had 365 shareholders on record.

Promoters: 50.91%Retail & Others: 49.09%
Mar 2026
QUARTER
50.91% Promoters
49.09% Retail & Others
Promoter holding - history
Now 50.91% · Mar 2026High 66.71% · Sep 2021Low 50.91% · Sep 2025
49%53.8%58.5%63.3%68%Sep 2021Mar 2022Sep 2022Sep 2023Sep 2024Sep 2025Sep 2021: 66.71%Dec 2021: 66.71%Mar 2022: 66.71%Jun 2022: 66.71%Sep 2022: 66.71%Mar 2023: 66.71%Sep 2023: 66.71%Mar 2024: 56.02%Sep 2024: 56.02%Mar 2025: 56.02%Sep 2025: 50.91%Mar 2026: 50.91%66.71%50.91%50.91%
Shareholding trend - last 6 quarters
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Sep 2023
Promoters50.91%50.91%56.02%56.02%56.02%66.71%
Public49.09%49.09%43.98%43.98%43.98%33.29%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Promoters50.91%56.02%56.02%66.71%66.71%
Public49.09%43.98%43.98%33.29%33.29%
Promoter change (YoY, %pts)-5.11+0.00-10.69+0.00-

Charges & Borrowings of Ganga Pharmaceuticals Ltd

Open charges
₹2.18 Cr
Satisfied charges
₹12.26 Cr
Breakdown by lending institutions
Others₹2.18 Cr
Latest charge details
DateLenderAmountStatus
14 Dec 2021 Others ₹34.54 Lakh Open
29 Sep 2021 Others ₹8 Lakh Open
18 Jul 2020 Others ₹20 Lakh Open
09 Jul 2020 Others ₹10 Lakh Open
25 Jul 2019 Others ₹1.45 Cr Open

Total charge records: 19 View all charges

Employees and EPFO Compliance at Ganga Pharmaceuticals Ltd

View historical data on people associated with Ganga Pharmaceuticals Ltd, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Ganga Pharmaceuticals Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Ganga Pharmaceuticals Ltd

Premium access

GST registrations and filing compliance for Ganga Pharmaceuticals Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Ganga Pharmaceuticals Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Ganga Pharmaceuticals Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ganga Pharmaceuticals Ltd

Premium access

MSME payment history for Ganga Pharmaceuticals Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ganga Pharmaceuticals Ltd

Premium access

Corporate group structure for Ganga Pharmaceuticals Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ganga Pharmaceuticals Ltd

Premium access

MCA filings and documents for Ganga Pharmaceuticals Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Ganga Pharmaceuticals Ltd

Activity
20 Sep 2025
Ganga Pharmaceuticals Ltd last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Directors
04 Jul 2025
Priti Bhaiya was appointed as a Company Secretary on 04 Jul 2025 & has been associated with this company since 1 year 21 days.
Activity
31 Mar 2025
Ganga Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Directors
27 Mar 2025
Munna Baijnath Chaurasia was appointed as a Director on 27 Mar 2025 & has been associated with this company since 1 year 4 months.
Directors
27 Mar 2025
Aman Mukesh Chaudhari was appointed as a Director on 27 Mar 2025 & has been associated with this company since 1 year 4 months.
Charges
14 Dec 2021
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100513449 was registered on 14 Dec 2021.

Frequently Asked Questions about Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd is an active public limited company in the healthcare sector based in Palghar, Maharashtra, India. It was incorporated on 11 September 1989 (37+ years old) and is registered under CIN L99999MH1989PLC053392. Listed on BSE: 539680.

Ganga Pharmaceuticals Ltd reported revenue of ₹2.83 Cr for FY 2026 (up 7.22% YoY) based on standalone BSE filings.

The current directors of Ganga Pharmaceuticals Ltd are:

The primary industry of Ganga Pharmaceuticals Ltd is healthcare. The company specifically operates in ayurvedic products and services. The company is currently active in this sector.

Yes. Ganga Pharmaceuticals Ltd is listed on BSE with code 539680.

Ganga Pharmaceuticals Ltd can be reached at the registered office: Gangatat Dhanvantri Marg Gopcharpada Virar E Palghar – 401305, Maharashtra, India – 401305, or through the website ayurvedganga.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available